ALK c.329G>A ;(p.W110*)

Variant ID: 2-30143197-C-T

NM_004304.4(ALK):c.329G>A;(p.W110*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients.

Translational Lung Cancer Research
Yue, Dongsheng D; Liu, Weiran W; Chen, Chen C; Zhang, Tao T; Ma, Yuchen Y; Cui, Longgang L; Gu, Yajun Y; Bei, Ting T; Zhao, Xiaochen X; Zhang, Bei B; Bai, Yuezong Y; Romero, Atocha A; Xu-Welliver, Meng M; Wang, Changli C; Zhang, Zhenfa Z; Zhang, Bin B
Publication Date: 2022-02

Variant appearance in text: ALK: W110*
PubMed Link: 35280315
Variant Present in the following documents:
  • tlcr-11-02-263-supplementary.pdf
View BVdb publication page



Comprehensive omic characterization of breast cancer in Mexican-Hispanic women.

Nature Communications
Romero-Cordoba, Sandra L SL; Salido-Guadarrama, Ivan I; Rebollar-Vega, Rosa R; Bautista-Piña, Veronica V; Dominguez-Reyes, Carlos C; Tenorio-Torres, Alberto A; Villegas-Carlos, Felipe F; Fernández-López, Juan C JC; Uribe-Figueroa, Laura L; Alfaro-Ruiz, Luis L; Hidalgo-Miranda, Alfredo A
Publication Date: 2021-04-14

Variant appearance in text: ALK: W110*
PubMed Link: 33854067
Variant Present in the following documents:
  • 41467_2021_22478_MOESM8_ESM.xlsx, sheet 9
View BVdb publication page